Filed before 2025Filed 1 February 2018
Ultivue, Inc. has sold $20.2M so far
Ultivue, Inc., a biotech company based in Cambridge, MA, has sold $20.2M so far in its equity round, according to a filing dated 1 February 2018.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 1 February 2018
- First filed
- 21 July 2017
- Round
- Equity round (amended filing)
- Amount sold
- $20.2M
- Offering size
- $20.5M
- Investors so far
- 11
- Based in
- Cambridge, MA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
2 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 78% of the 1,729 tracked raises with an amount filed in 2018, and than 60% of the 160 in biotech.
Ultivue, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 25 Jul 2024 | New filing | $3.32M | Another raise |
| 28 Jun 2019 | New filing | $26.5M | Another raise |
| 1 Feb 2018 | Amended filing | $20.2M | This raise |
| 21 Jul 2017 | New filing | $10.1M | This raise |
More with ARCH on the board
- SonoThera, Inc.$125M
- Ollin Biosciences, Inc.$156M
- Vizgen, Inc.$47.8M
- Pheast Therapeutics, Inc.$24.6M
Other unannounced rounds
- Thoughtform, Inc.$6.6M
- ProvenAir Technologies, Inc.$488K
- Gravitics, Inc.$17M
- SurgiBox Inc.$486K
- Voxel Labs Inc.$10M
- DVx Atomic Co.$18.5M
Seen it announced?
Send the link and the check will look at it.